Lindleyin
CAS No. 59282-56-3
Lindleyin ( —— )
产品货号. M22052 CAS No. 59282-56-3
Lindleyin is a novel phytoestrogen and might trigger many of the biological responses evoked by the physiological estrogens.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2616 | 有现货 |
|
10MG | ¥3888 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Lindleyin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Lindleyin is a novel phytoestrogen and might trigger many of the biological responses evoked by the physiological estrogens.
-
产品描述Lindleyin is a novel phytoestrogen and might trigger many of the biological responses evoked by the physiological estrogens.One herbal extract, Rhei rhizoma (rhubarb), acts as an agonist to both ERalpha and ERbeta. The phytochemical Lindleyin, a major component of rhubarb, might contribute to this estrogenic activity through ERalpha and ERbeta. 4-Hydroxytamoxifen, an ER antagonist, completely reversed the estrogenic activity of Lindleyin. Lindleyin binds to ERalpha in vitro, as demonstrated using a fluorescent polarization assay. The in vivo effect of rhubarb extract was studied using a vitellogenin assay system in the freshwater fish, Japanese medaka (Oryzias latipes). There were marked increases in serum vitellogenin levels in male medaka exposed to rhubarb extract.
-
同义词——
-
通路Endocrinology/Hormones
-
靶点Estrogen Receptor/ERR
-
受体Estrogen Receptor/ERR;Estrogen/progestogen Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number59282-56-3
-
分子量478.45
-
分子式C23H26O11
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC(=O)CCC1=CC=C(O[C@@H]2O[C@H](COC(=O)C3=CC(O)=C(O)C(O)=C3)[C@@H](O)[C@H](O)[C@H]2O)C=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.The phytochemical lindleyin, isolated from Rhei rhizoma, mediates hormonal effects through estrogen receptors.J Endocrinol. 2002 Nov;175(2):289-96.
产品手册
关联产品
-
Nylestriol
Nylestriol is an agonist of estrogen receptor.
-
Medicarpin (b)
(+)-Medicarpin potently inhibits osteoclastogenesis and promotes bone healing and increases bone mass by osteoblast differentiation with estrogen receptor (ER) β-mediated osteogenic action.
-
Acolbifene
Acolbifene is a selective antagonist of estrogen receptors with IC50s of 2 nM and 0.4 nM for estradiol-induced transcriptional activity of ERα and ERβ. Acolbifene shows an anticarcinogenic property.